EnvisionTEC

EnvisionTEC
Private
Founded Gladbeck, Germany, 2002
Area served
Worldwide
Key people
Al Siblani (CEO)
Products 3D printers
Rapid prototyping solutions
Direct digital manufacturing solutions
Website envisiontec.com

EnvisionTEC is a manufacturer of 3D Printers including software and material. The company was founded in 2002 in Marl, Germany[1] and now has two corporate headquarters located in Gladbeck, Germany and Dearborn, MI. EnvisionTEC produces 3D Printers that are used for a wide range of dental,[2] medical,[3] mold making, animation[4] prototyping, biofabrication[5] and other applications.

Technology

EnvisionTEC uses two types of technology to cure liquid resin into a three-dimensional object.

EnvisionTEC utilizes a third technology with the 3D-Bioplotter.[7] Extruding multiple materials in three dimensions using pressure. Materials range from a viscous paste to a liquid, and are inserted using syringes moving in three dimensions. Air or mechanical pressure is applied to the syringe, which then deposits a strand of material for the length of movement and time the pressure is applied. Parallel strands are plotted in one layer. For the following layer, the direction of the strands is turned over the center of the object, creating a fine mesh with good mechanical properties and mathematically well-defined porosity.

References

  1. "Company Overview", EnvisionTEC Official Website
  2. "Trends in 3D Printing of Customised Medical Devices", Medical Plastic News
  3. Rakesh Sharma, "The 3D Printing Revolution You Have Not Heard About", Forbes
  4. Todd Grimm, "EnvisionTEC Supports Aardman's Latest Feature Film", Engineering.com
  5. Christopher Barnatt, "3D Printing", Explaining the Future
  6. Myriam Joire,"Texas Instruments brings sci-fi tech to life with DLP", engadget
  7. Kucklick, Theodore R. (December 2012). The Medical Device R & D Handbook (2nd ed.). CRC Press. pp. 158–159. ISBN 978-1-4398-1189-4.

See also

This article is issued from Wikipedia - version of the Tuesday, February 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.